Bladder Cancer Screening Trial

Launched by UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER · Dec 1, 2022

Keywords

ClinConnect Summary

The Bladder Cancer Screening Trial is studying whether regular urine tests can help detect bladder cancer earlier in people who are at higher risk. Researchers want to find out if testing urine every six months for two years can improve early diagnosis of bladder cancer, which can lead to better treatment outcomes. This trial is currently looking for participants who are at least 50 years old, have a significant history of smoking (15 years of smoking 15 cigarettes a day), or have worked in jobs that expose them to certain chemicals for at least 15 years, such as in textile or painting industries.

Eligible participants will be asked to take a simple urine test every six months for two years. It's important to note that individuals with a history of bladder, kidney, or prostate cancer, or those who have had tests for blood in their urine in the past two years, cannot join the study. Participants will help researchers understand the potential benefits of regular screening for bladder cancer, which currently does not have an accepted screening method. Your involvement could contribute to important findings that may improve bladder cancer detection in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 50
• • Smoking: ≥15 pack-year smoking history
• • Occupation:≥ 15 years of occupational exposures including: textile worker, painter, dry cleaners
• Exclusion Criteria:
• • Prior history of bladder, kidney, or prostate cancer
• • Prior evaluation of micro or gross hematuria within the last 2 years
• • Do not provide informed consent

Trial Officials